This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
This study looked at how pyridoxine, also known as vitamin B6, might help reduce neuropsychiatric side effects caused by the epilepsy medication levetiracetam in children and adolescents.
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at how well the Modified Mini-Mental State Examination for Children (MMSEc) can identify intellectual disabilities in children aged 6 to 14.
Researchers studied the neurological effects of familial Mediterranean fever (FMF) in children under 18 years old.
This study looked at how epilepsy affects the oral and dental health of children.
A study was conducted to evaluate the effectiveness and safety of a medication called cenobamate (CNB) in treating patients with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy that often starts in childhood.